Company: ABUS
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012305
Chunk: 54

Company: Arbutus Biopharma Corp
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 54
---
 candidates and other business objectives. Additionally, grants of equity awards, primarily stock options and restricted stock units, to our executive officers are intended to incentivize future value creation and to align the long-term interests of our executive officers with shareholders. For further discussion of how the Company views its executive compensation structure, including alignment with Company performance, see page 24. The Compensation Committee did not consider the pay versus performance disclosure below in making its pay decisions for any of the years shown. The “Compensation Actually Paid”, which is presented in the table below, is defined by the SEC and does not reflect amounts actually paid, earned or received by our Named Executive Officers. A significant portion of the “Compensation Actually Paid” amounts shown relate to changes in values of unvested equity awards over the course of the applicable reporting year. These unvested awards remain subject to significant risk from forfeiture conditions and possible future declines in value based on changes in our share price. The ultimate values actually realized by our Named Executive Officers from unvested equity awards, if any, cannot be determined until the awards fully vest and are exercised or settled, as the case may be.

| Year |     |       Summary 
  Compensation 
   Table Total 
 for PEO(1)(2) |     |  Compensation 
 Actually Paid 
     to PEO(3) |     |         Average 
         Summary 
    Compensation 
 Table Total for 
         non-PEO 
      NEOs(1)(2) |     |       Average 
  Compensation 
 Actually Paid 
    to non-PEO 
       NEOs(3) |     |        Value of 
   Initial Fixed 
 $100 Investment 
  based on Total 
     Shareholder 
          Return |     |           Net 
 Income/(Loss) |
| 2024 |     |    $2,110,083 |     |    $2,592,023 |     |      $1,781,092 |     |    $2,207,723 |     |             $84 |     |  -$69,920,000 |
| 2023 |     |    $3,385,984 |     |    $3,268,381 |     |      $1,692,632 |     |    $1,594,078 |     |             $64 |     |  -$72,849,000 |
| 2022 |     |    $2,645,657 |     |      $844,918 |     |      $